FP7Individual fellowship2009–2011

FAR-QUAD · FoldAmeRs : a new family of G-QUADruplex ligands

FP7 — People (Marie Curie Actions)

Duration
2009-03-01 → 2011-02-28
EU contribution
€174,536
Participants
1
Scheme
MC-IIF

Lines connect the coordinator with its partners. CORDIS does not always give exact coordinates for projects before 2014. These points are placed at city or country level.

Results in brief

FoldAmeRs: a new family of G-QUADruplex ligands

Project objectives It has been known that G-rich nucleic acids have a propensity to form four stranded structures called quadruplexes in vitro. Recently, it has been discovered that they do indeed play a general physiological role and are highly relevant targets for cancer therapy. Many different ligands have been synthesised so far, however, their common feature is their flatness which allows stacking on the top of quadruplex platform. This project was initiated by the serendipitously discovery that helically folded molecule, called foldamers, could strongly interact with the human telomeric quadruplex, suggesting a different mechanism. The main objectives of this project were: i) to develop new G-quadruplex ligands having high affinity and specificity and ii) to understand the elements responsible for specific interaction of the ligand by the structure determination of quadruplex-foldamer complex by X-ray diffraction. Description of the work performed since the beginning of the project The work performed consisted in: i) the chemical synthesis of a consequent number of foldamers without various modifications, including backbone and side chains variations; ii) their biophysical studies with six different biologically relevant quadruplex sequences; iii) the selection of DNA sequences against the best foldamer and iv) cristallogenesis of quadruplexes in absence or presence of foldamers. The main results achieved so far 1) Almost all of our new macrocycles and foldamers 1-12 showed significant potential for quadruplexes stabilisation without any evidence of duplex stabilisation. 2) Biophysical studies revealed that the octacationic foldamer 8 is the best ligand for stabilising quadruplexes DNA known so far. 3) Structure activity relationships allowed us to determine features required for a foldamers to be a good quadruplex ligand (backbone, side chains and nature of extremities). 4) Using SELEX technology, we discovered that foldamer 8 selected oligonucleotides with a G-quadruplex conformation, which clearly indicates the high affinity of this foldamer for this DNA folded structure. 5) Complex formation between quadruplex and foldamers is specific from this latest, depending on its helicity, as demonstrated by tethering a correct chiral group at one extremity. The expected final results and their potential impact and use As foldamer 8 is the best ligand for G-quadruplex structures known up-to-date, promising application will be considered. We will take advantage of its lack of sequence specificity to use it as detection probe of G-quadruplex structure within the genome. In the same, we are still optimistic to obtain a X-ray structure of a complex and then get access to of interaction between the two partner. This will allow us to start designing foldamers for sequence specific recognition of quadruplex.

Data: CORDIS, © European Union

Project objective

This proposal focuses on the formation of complex between DNA G-quadruplexes and a new family of synthetic ligands, which might be relevant for cancer therapy. The enzymatic acitivity of telomerase is critical to the immortality of most human cancer cell lines. However, telomeric DNA may fold into guanine quadruplex structures which are not competent substrates for telomerase. Therefore, the use of small molecule ligands to induce quadruplex stabilisation in telomeric DNA has potential as an anti-cancer strategy. A European collaboration recently engaged between I. Huc (Bordeaux, France) and S. Balasubramanian (Cambridge, UK) groups already led to the identification of a very promising compound, with exceptionnal potential for stabilising human G-quadruplex telomer. In addition a three dimensionnal helical compound (foldamer) has shown interesting activity. This project, involving chemistry, biology and biophysic, aims i) to systematically design and develop new analogues of this promising candidate, based on aromatic delta-peptide chemistry; ii) to evaluate their G-quadruplex binding affinity in telomere and others systems; iii) to establish structure-activity relationships; iv) to determine the key elements necessary for specific G-quadruplex recognition by solving the structure of the first ligand complexed with G-quadruplex. This original interdisciplinary proposal involves two international leading groups in their respective field, to develop new tools and knowledge on the growing interest on natural G-quadruplexes as new target for anti-cancer strategy. The applicant will have a crucial role in the development of this collaboration and will become an active and efficient third partner, when returning back to China at the end of the fellowship.

Original text from CORDIS.

Participants

  • UNIVERSITE BORDEAUX I · TALENCECoordinatorCity levelFrance

Links

Data: CORDIS, © European Union